Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Punit P Seth

Showing results (51-60 of 108) with videos related to

Pageof 11
Sort By:
Journal of Medicinal Chemistry|July 18, 2020
Targeted Delivery of Antisense Oligonucleotides Using Neurotensin PeptidesMehran Nikan, Michael Tanowitz, Chrissa A Dwyer, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2004
Biaryl guanidine inhibitors of in vitro HCV-IRES activityElizabeth A Jefferson, Punit P Seth, Dale E Robinson, et al.
Nucleic Acids Research|March 18, 2020
Mechanisms of palmitic acid-conjugated antisense oligonucleotide distribution in miceAlfred E Chappell, Hans J Gaus, Andres Berdeja, et al.
Nucleic Acid Therapeutics|July 21, 2022
The Combination of Mesyl-Phosphoramidate Inter-Nucleotide Linkages and 2'-<i>O</i>-Methyl in Selected Positions in the Antisense Oligonucleotide Enhances the Performance of RNaseH1 Active PS-ASOsLingdi Zhang, Xue-Hai Liang, Cheryl Li De Hoyos, et al.
Nucleic Acid Therapeutics|April 28, 2017
Co-Administration of an Excipient Oligonucleotide Helps Delineate Pathways of Productive and Nonproductive Uptake of Phosphorothioate Antisense Oligonucleotides in the LiverAaron J Donner, Edward V Wancewicz, Heather M Murray, et al.
Nucleic Acids Research|April 3, 2012
TricycloDNA-modified oligo-2'-deoxyribonucleotides reduce scavenger receptor B1 mRNA in hepatic and extra-hepatic tissues--a comparative study of oligonucleotide length, design and chemistrySue Murray, Damian Ittig, Erich Koller, et al.
ACS Medicinal Chemistry Letters|June 18, 2021
Site-specific Incorporation of 2',5'-Linked Nucleic Acids Enhances Therapeutic Profile of Antisense OligonucleotidesThazha P Prakash, Jinghua Yu, Wen Shen, et al.
Nucleic Acids Research|February 25, 2016
Stabilin-1 and Stabilin-2 are specific receptors for the cellular internalization of phosphorothioate-modified antisense oligonucleotides (ASOs) in the liverColton M Miller, Aaron J Donner, Emma E Blank, et al.
Journal of the American Chemical Society|March 24, 2020
Origins of the Increased Affinity of Phosphorothioate-Modified Therapeutic Nucleic Acids for ProteinsMalwina Hyjek-Składanowska, Timothy A Vickers, Agnieszka Napiórkowska, et al.
Journal of Medicinal Chemistry|November 10, 2010
Configuration of the 5'-methyl group modulates the biophysical and biological properties of locked nucleic acid (LNA) oligonucleotidesPunit P Seth, Charles R Allerson, Andrew Siwkowski, et al.
Pageof 11

Showing results (51-60 of 108) with videos related to

Sort By:
Pageof 11
Journal of Medicinal Chemistry|July 18, 2020
Targeted Delivery of Antisense Oligonucleotides Using Neurotensin PeptidesMehran Nikan, Michael Tanowitz, Chrissa A Dwyer, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2004
Biaryl guanidine inhibitors of in vitro HCV-IRES activityElizabeth A Jefferson, Punit P Seth, Dale E Robinson, et al.
Nucleic Acids Research|March 18, 2020
Mechanisms of palmitic acid-conjugated antisense oligonucleotide distribution in miceAlfred E Chappell, Hans J Gaus, Andres Berdeja, et al.
Nucleic Acid Therapeutics|July 21, 2022
The Combination of Mesyl-Phosphoramidate Inter-Nucleotide Linkages and 2'-<i>O</i>-Methyl in Selected Positions in the Antisense Oligonucleotide Enhances the Performance of RNaseH1 Active PS-ASOsLingdi Zhang, Xue-Hai Liang, Cheryl Li De Hoyos, et al.
Nucleic Acid Therapeutics|April 28, 2017
Co-Administration of an Excipient Oligonucleotide Helps Delineate Pathways of Productive and Nonproductive Uptake of Phosphorothioate Antisense Oligonucleotides in the LiverAaron J Donner, Edward V Wancewicz, Heather M Murray, et al.
Nucleic Acids Research|April 3, 2012
TricycloDNA-modified oligo-2'-deoxyribonucleotides reduce scavenger receptor B1 mRNA in hepatic and extra-hepatic tissues--a comparative study of oligonucleotide length, design and chemistrySue Murray, Damian Ittig, Erich Koller, et al.
ACS Medicinal Chemistry Letters|June 18, 2021
Site-specific Incorporation of 2',5'-Linked Nucleic Acids Enhances Therapeutic Profile of Antisense OligonucleotidesThazha P Prakash, Jinghua Yu, Wen Shen, et al.
Nucleic Acids Research|February 25, 2016
Stabilin-1 and Stabilin-2 are specific receptors for the cellular internalization of phosphorothioate-modified antisense oligonucleotides (ASOs) in the liverColton M Miller, Aaron J Donner, Emma E Blank, et al.
Journal of the American Chemical Society|March 24, 2020
Origins of the Increased Affinity of Phosphorothioate-Modified Therapeutic Nucleic Acids for ProteinsMalwina Hyjek-Składanowska, Timothy A Vickers, Agnieszka Napiórkowska, et al.
Journal of Medicinal Chemistry|November 10, 2010
Configuration of the 5'-methyl group modulates the biophysical and biological properties of locked nucleic acid (LNA) oligonucleotidesPunit P Seth, Charles R Allerson, Andrew Siwkowski, et al.
Pageof 11